Cargando...
Perspectives of U.S. Private Payers on Insurance Coverage for Pediatric and Prenatal Exome Sequencing – Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)
PURPOSE: Exome sequencing (ES) has the potential to improve management of congenital anomalies and neurodevelopmental disorders in fetuses, infants and children. U.S. payers are key stakeholders in patient access to ES. We examined how payers view insurance coverage and clinical utility of pediatric...
Guardado en:
| Publicado en: | Genet Med |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004856/ https://ncbi.nlm.nih.gov/pubmed/31501586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-019-0650-7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|